In a single-center, prospective study, Leizour and associates (2016) evaluated the safety and effectiveness of the adjustable suburethral sling Remeex in the treatment of male SUI. Participants were patients treated for SUI after radical prostatectomy (RP) or transurethral resection of prostate. The severity of incontinence was evaluated by the number of pads used per day. Success rate, complications and number of adjustments were studied. From February 2011 to May 2015, Remeex was implanted in 25 patients. The average pre-operative number of pads used per day was 3.8 (± 1.8). Sling tension has been adjusted the day after surgery in all patients. Mean follow-up was 31 months (± 15). During follow-up, 6 patients did not need any re-adjustment (24 %) and 15 patients (60 %) had to be re-adjusted. One Remeex system had to be completely removed because of a sub-occlusive syndrome; 3 patients had early infection requiring partial system removal (Varitensor). At the end of follow-up, 9 patients were cured (36 %), 9 patients (36 %) were significantly improved and 7 patients (28 %) were not improved; 5 patients were waiting for a new re-adjustment. The authors concluded that in this short series of patients who had prostatic surgery, at mid-term follow-up, the placement of an adjustable suburethral sling was associated with an improvement or cure of UI symptoms in 2/3 of cases.